A Strategy for Modulation of Enzymes in the Ubiquitin System
暂无分享,去创建一个
Brian Raught | Mike Tyers | Sachdev S Sidhu | Laurence Pelletier | Michael F Moran | Abdellah Allali-Hassani | Yihui Fan | Jason Moffat | Jiefei Tong | Pak-Kei Chan | Masoud Vedadi | Daniel Durocher | M. Tyers | M. Moran | D. Durocher | J. Moffat | L. Pelletier | B. Raught | F. Sicheri | M. Vedadi | Jiefei Tong | S. Sidhu | D. Rotin | Yanling Zhao | Jianhua Yang | P. Garg | G. Avvakumov | J. Walker | A. Ernst | Konstantina Karamboulas | D. Neculai | A. Neculai | A. Allali-Hassani | Y. Juang | S. Dhe-Paganon | Yihui Fan | P. Alberts | Avinash K. Persaud | A. Vorobyov | L. Beatty | Pak-kei Chan | Marie-Claude Landry | C. Yeh | E. Zeqiraj | Frank Sicheri | John R Walker | Sirano Dhe-Paganon | Andreas Ernst | George Avvakumov | Yanling Zhao | Philipp Alberts | Avinash Persaud | Ana-Mirela Neculai | Dante Neculai | Andrew Vorobyov | Pankaj Garg | Linda Beatty | Yu-Chi Juang | Marie-Claude Landry | Christina Yeh | Elton Zeqiraj | Konstantina Karamboulas | Daniela Rotin | Jianhua Yang
[1] Q. Dou,et al. Targeting the ubiquitin–proteasome system for cancer therapy , 2013, Expert opinion on therapeutic targets.
[2] M. Rapé,et al. The Ubiquitin Code , 2012, Annual review of biochemistry.
[3] D. Durocher,et al. OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. , 2012, Molecular cell.
[4] B. Raught,et al. The SUMO-specific isopeptidase SENP2 associates dynamically with nuclear pore complexes through interactions with karyopherins and the Nup107-160 nucleoporin subcomplex , 2011, Molecular biology of the cell.
[5] C. Loch,et al. Role of ubiquitylation and USP8‐dependent deubiquitylation in the endocytosis and lysosomal targeting of plasma membrane KCa3.1 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] Xinna Zhang,et al. USP4 inhibits p53 through deubiquitinating and stabilizing ARF‐BP1 , 2011, The EMBO journal.
[7] V. Dixit,et al. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. , 2011, Molecular cell.
[8] Matthew D. Smith,et al. Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. , 2011, Cancer research.
[9] J. E. V. van Leeuwen,et al. ERBB2 is a target for USP8-mediated deubiquitination. , 2011, Cellular signalling.
[10] R. Klevit,et al. E2s: structurally economical and functionally replete. , 2011, The Biochemical journal.
[11] P. Cohen,et al. Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases? , 2010, Cell.
[12] N. Donato,et al. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. , 2010, Cancer research.
[13] P. Nash,et al. Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex* , 2010, The Journal of Biological Chemistry.
[14] Tony Pawson,et al. ProHits: an integrated software platform for mass spectrometry-based interaction proteomics , 2010, Nature Biotechnology.
[15] A. Gingras,et al. Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1 , 2010, Nature.
[16] Min Jae Lee,et al. Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of Usp14 , 2010, Nature.
[17] F. Colland. The therapeutic potential of deubiquitinating enzyme inhibitors. , 2010, Biochemical Society transactions.
[18] J. Boeke,et al. Specificity of the BRISC Deubiquitinating Enzyme Is Not Due to Selective Binding to Lys63-linked Polyubiquitin* , 2009, The Journal of Biological Chemistry.
[19] John Parkinson,et al. Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays , 2009, Molecular systems biology.
[20] Jun Qin,et al. Ubiquitin-specific Peptidase 21 Inhibits Tumor Necrosis Factor α-induced Nuclear Factor κB Activation via Binding to and Deubiquitinating Receptor-interacting Protein 1* , 2009, The Journal of Biological Chemistry.
[21] D. Komander. The emerging complexity of protein ubiquitination. , 2009, Biochemical Society transactions.
[22] David Komander,et al. Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.
[23] M. Moran,et al. Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041* , 2009, Molecular & Cellular Proteomics.
[24] Ying Zhang,et al. DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors , 2009, Cell cycle.
[25] Troels Z. Kristiansen,et al. K63‐specific deubiquitination by two JAMM/MPN+ complexes: BRISC‐associated Brcc36 and proteasomal Poh1 , 2009, The EMBO journal.
[26] E. Fiebiger,et al. Structural basis and specificity of human otubain 1-mediated deubiquitination. , 2009, The Biochemical journal.
[27] L. Luttrell,et al. Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor. , 2009, Biochemistry.
[28] Yili Yang,et al. Targeting the ubiquitin‐proteasome system for cancer therapy , 2009, Cancer science.
[29] Tatiana A. Tatusova,et al. NCBI Reference Sequences: current status, policy and new initiatives , 2008, Nucleic Acids Res..
[30] B. Kay,et al. High-throughput biotinylation of proteins. , 2009, Methods in molecular biology.
[31] B. Kessler,et al. Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: Emerging patterns and molecular principles , 2008, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
[32] Robert Burke,et al. ProteoWizard: open source software for rapid proteomics tools development , 2008, Bioinform..
[33] A. Ciechanover,et al. Itch: a HECT-type E3 ligase regulating immunity, skin and cancer , 2008, Cell Death and Differentiation.
[34] W. Li,et al. Polyubiquitin chains: functions, structures, and mechanisms , 2008, Cellular and Molecular Life Sciences.
[35] M. Moran,et al. Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. , 2008, Journal of proteome research.
[36] F. Colland,et al. Targeting ubiquitin specific proteases for drug discovery. , 2008, Biochimie.
[37] S. Knapp,et al. A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases , 2007, Proceedings of the National Academy of Sciences.
[38] J. Wrana,et al. Autoinhibition of the HECT-Type Ubiquitin Ligase Smurf2 through Its C2 Domain , 2007, Cell.
[39] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[40] K. Knobeloch,et al. Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In Vivo , 2007, Molecular and Cellular Biology.
[41] F. Mackenzie,et al. Amino-terminal Dimerization, NRDP1-Rhodanese Interaction, and Inhibited Catalytic Domain Conformation of the Ubiquitin-specific Protease 8 (USP8)* , 2006, Journal of Biological Chemistry.
[42] J. Hurley,et al. Ubiquitin-binding domains. , 2006, The Biochemical journal.
[43] P. Febbo,et al. The isopeptidase USP2a protects human prostate cancer from apoptosis. , 2006, Cancer research.
[44] A. D'arcy,et al. Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2 , 2006, Structure.
[45] D. Allison,et al. Increased Expression of Thymidylate Synthetase (TS), Ubiquitin Specific Protease 10 (USP10) and Survivin is Associated with Poor Survival in Glioblastoma Multiforme (GBM) , 2006, Journal of Neuro-Oncology.
[46] I. Prior,et al. The Ubiquitin Isopeptidase UBPY Regulates Endosomal Ubiquitin Dynamics and Is Essential for Receptor Down-regulation* , 2006, Journal of Biological Chemistry.
[47] Jay Painter,et al. Electronic Reprint Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion , 2005 .
[48] K. Inoki,et al. TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase* , 2006, Journal of Biological Chemistry.
[49] René Bernards,et al. A Genomic and Functional Inventory of Deubiquitinating Enzymes , 2005, Cell.
[50] Yigong Shi,et al. Structure and mechanisms of the proteasome‐associated deubiquitinating enzyme USP14 , 2005, The EMBO journal.
[51] S. Sidhu. Phage display in biotechnology and drug discovery , 2005 .
[52] K. Wilkinson,et al. Derivitization of the C-terminus of ubiquitin and ubiquitin-like proteins using intein chemistry: methods and uses. , 2005, Methods in enzymology.
[53] K. Nakayama,et al. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase , 2004, Nature Cell Biology.
[54] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[55] C. Pickart,et al. Ubiquitin: structures, functions, mechanisms. , 2004, Biochimica et biophysica acta.
[56] David S. Wishart,et al. SuperPose: a simple server for sophisticated structural superposition , 2004, Nucleic Acids Res..
[57] Robertson Craig,et al. TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.
[58] B. Vogelstein,et al. HAUSP is Required for p53 Destabilization , 2004, Cell cycle.
[59] Muyang Li,et al. A dynamic role of HAUSP in the p53-Mdm2 pathway. , 2004, Molecular cell.
[60] Muyang Li,et al. Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin Aldehyde , 2002, Cell.
[61] Wladek Minor,et al. Automatic System for Crystallographic Data Collection and Analysis , 2002 .
[62] S. Sidhu,et al. Phage display for selection of novel binding peptides. , 2000, Methods in enzymology.
[63] J. Merchant,et al. ZBP-99 defines a conserved family of transcription factors and regulates ornithine decarboxylase gene expression. , 1999, Biochemical and biophysical research communications.
[64] J. Ashby. References and Notes , 1999 .
[65] N. Copeland,et al. The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice , 1998, Nature Genetics.
[66] R. Stein,et al. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. , 1998, Biochemistry.
[67] L. Presta,et al. Mutational Analysis of Thrombopoietin for Identification of Receptor and Neutralizing Antibody Sites* , 1997, The Journal of Biological Chemistry.
[68] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[69] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[70] T. Creighton. Methods in Enzymology , 1968, The Yale Journal of Biology and Medicine.